333 related articles for article (PubMed ID: 6939934)
21. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones.
Aboud M; Kingsmore S; Segal S
Nat Immun; 1993; 12(1):17-24. PubMed ID: 8431660
[TBL] [Abstract][Full Text] [Related]
22. Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.
Strzadała L; Rak J; Kuśnierczyk H
Arch Immunol Ther Exp (Warsz); 1985; 33(6):825-9. PubMed ID: 3833119
[TBL] [Abstract][Full Text] [Related]
23. In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.
Raz A; Hanna N; Fidler IJ
J Natl Cancer Inst; 1981 Jan; 66(1):183-9. PubMed ID: 6935459
[TBL] [Abstract][Full Text] [Related]
24. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
25. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (1). Assay for time course of development of metastasis.
Ohizumi Y; Maezawa H; Mori T
Tokai J Exp Clin Med; 1987 Nov; 12(4):229-35. PubMed ID: 3503392
[TBL] [Abstract][Full Text] [Related]
26. Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors.
Talmadge JE; Fidler IJ
J Natl Cancer Inst; 1982 Oct; 69(4):975-80. PubMed ID: 6750200
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of heparin plus cortisone acetate on endothelial cell growth both in cultures and in tumor masses.
Sakamoto N; Tanaka NG; Tohgo A; Osada Y; Ogawa H
J Natl Cancer Inst; 1987 Mar; 78(3):581-5. PubMed ID: 2434705
[TBL] [Abstract][Full Text] [Related]
28. A demonstration of a strain related restriction effect in the formation of experimental metastases.
Jack AS; McVeigh KL
J Pathol; 1987 May; 152(1):37-45. PubMed ID: 3625393
[TBL] [Abstract][Full Text] [Related]
29. H-2-linked genetic control of resistance to histocompatible tumors.
Williams RM; Dorf ME; Benacerraf B
Cancer Res; 1975 Jun; 35(6):1586-90. PubMed ID: 805662
[TBL] [Abstract][Full Text] [Related]
30. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
31. [Role of the cellular inoculation dose in the development of the inhibitory effect of transplantable tumors on metastasis].
Arkhipov SA; Iunker VM; Gruntenko EV
Vopr Onkol; 1985; 31(3):77-83. PubMed ID: 3992963
[TBL] [Abstract][Full Text] [Related]
32. Effects of experimental hyper- and hypothyroidism on natural defense activities against Lewis lung carcinoma and its spontaneous pulmonary metastases in C57BL/6 mice.
Kinoshita S; Sone S; Yamashita T; Tsubura E; Ogura T
Tokushima J Exp Med; 1991 Jun; 38(1-2):25-35. PubMed ID: 1948998
[TBL] [Abstract][Full Text] [Related]
33. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
Pál K; Kopper L; Lapis K
Invasion Metastasis; 1983; 3(3):174-82. PubMed ID: 6677625
[TBL] [Abstract][Full Text] [Related]
34. Host's immune state and kinetics of local tumor growth control--progression of postoperative lung metastasis.
Gorelik E; Segal S; Feldman M
Recent Results Cancer Res; 1980; 75():20-8. PubMed ID: 7232832
[TBL] [Abstract][Full Text] [Related]
35. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice.
Palumbo JS; Potter JM; Kaplan LS; Talmage K; Jackson DG; Degen JL
Cancer Res; 2002 Dec; 62(23):6966-72. PubMed ID: 12460914
[TBL] [Abstract][Full Text] [Related]
37. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice.
Nomi S; Naito K; Kahan BD; Pellis NR
Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631
[TBL] [Abstract][Full Text] [Related]
38. Relationship between primary tumor volume and lung metastasis in Lewis lung carcinoma (II). Tumor bed effect.
Ohizumi Y; Maezawa H; Mori T
Tokai J Exp Clin Med; 1987 Nov; 12(4):237-42. PubMed ID: 3503393
[TBL] [Abstract][Full Text] [Related]
39. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma.
Yuhas JM; Pazmiño NH; Wagner E
Cancer Res; 1975 Jan; 35(1):237-41. PubMed ID: 162863
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
Olsson L; Kiger N; Kronstrom H
Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]